Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial.

TitleGrowth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial.
Publication TypeJournal Article
Year of Publication2011
AuthorsMuthén, B, Asparouhov T, Hunter AM, Leuchter AF
JournalPsychological methods
Volume16
Issue1
Pagination17-33
Date Published2011 Mar
ISSN1939-1463
KeywordsAdolescent, Adult, Aged, Antidepressive Agents, Data Interpretation, Statistical, Depressive Disorder, Major, Humans, Likelihood Functions, Middle Aged, Models, Statistical, Patient Dropouts, Randomized Controlled Trials as Topic, Young Adult
Abstract

This article uses a general latent variable framework to study a series of models for nonignorable missingness due to dropout. Nonignorable missing data modeling acknowledges that missingness may depend not only on covariates and observed outcomes at previous time points as with the standard missing at random assumption, but also on latent variables such as values that would have been observed (missing outcomes), developmental trends (growth factors), and qualitatively different types of development (latent trajectory classes). These alternative predictors of missing data can be explored in a general latent variable framework with the Mplus program. A flexible new model uses an extended pattern-mixture approach where missingness is a function of latent dropout classes in combination with growth mixture modeling. A new selection model not only allows an influence of the outcomes on missingness but allows this influence to vary across classes. Model selection is discussed. The missing data models are applied to longitudinal data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, the largest antidepressant clinical trial in the United States to date. Despite the importance of this trial, STAR*D growth model analyses using nonignorable missing data techniques have not been explored until now. The STAR*D data are shown to feature distinct trajectory classes, including a low class corresponding to substantial improvement in depression, a minority class with a U-shaped curve corresponding to transient improvement, and a high class corresponding to no improvement. The analyses provide a new way to assess drug efficiency in the presence of dropout.

DOI10.1111/j.1460-9568.2012.08134.x
Alternate JournalPsychol Methods